Rossby Financial, Lcc Roivant Sciences Ltd. Transaction History
Rossby Financial, Lcc
- $271 Billion
- Q2 2025
A detailed history of Rossby Financial, Lcc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Rossby Financial, Lcc holds 10,000 shares of ROIV stock, worth $115,700. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$115,700% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
350Shares Held
495MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$761 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$716 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$532 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$455 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$416 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...